Gregory Ginger bought BIIB
February 7, 2025 · Form 4 insider transaction
Gregory Ginger bought 1,635 shares of Biogen Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Acquired (buy-side)
Shares
1,635
Price
$0.00
Total value
N/A
InsiderGregory Ginger
Role—
CompanyBiogen Inc. (BIIB)
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateFebruary 7, 2025
Filing dateFebruary 10, 2025
Shares owned after15,312
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Includes 93.3846 shares acquired under the Biogen Inc. employee stock purchase plan on 3/31/2024.